Logo

American Heart Association

  12
  0


Final ID:

But There’s a Pill for That! What is the role of lifestyle in the era GLP-1s?

  • Ard, Jamy  ( Wake Forest School of Medicine , Winston Salem , North Carolina , United States )
  • Davies, Melanie  ( University of Leicester , Leicester , United Kingdom )
  • Neeland, Ian  ( University Hospitals - Case Western , Cleveland , Ohio , United States )
  • Author Disclosures:
    Jamy Ard: DO NOT have relevant financial relationships | Melanie Davies: No Answer | Ian Neeland: DO have relevant financial relationships ; Consultant:Novo Nordisk:Past (completed) ; Advisor:Eli Lilly and Co.:Past (completed) ; Speaker:Bayer Pharmaceuticals:Active (exists now) ; Speaker:Boehringer Ingelheim/Lilly Alliance:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Navigating the Mix of Meds and Lifestyle for Obesity Medicine

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
Obesity Pharmacotherapy – where are we now?

Stanford Fatima, Kosiborod Mikhail

What’s the tipping point? When to initiate pharmacotherapy and can we ever stop?

Conroy Molly, Wadden Thomas, Kushner Robert, Jastreboff Ania, Almandoz Jaime, Abushamat Layla

You have to be authorized to contact abstract author. Please, Login
Not Available